Oz Medicann Group (OMG) has officially rolled out its AI-powered GP assistant and patient co-pilot Ask Sam in Australia, with Dr Sara McDonald appointed to lead the initiative.
According to OMG, the virtual assistant cuts through compliance burdens, documentation requirements, and treatment planning for healthcare providers, freeing them to concentrate on direct patient care.
On the patient side, the platform offers on-demand access to consultations, prescriptions, and same-day dispensing, giving patients greater control over managing their own health.
Built on advanced generative AI and trained across more than 150 years of medical data, Ask Sam has been calibrated to local conditions, including Australian healthcare standards and medicinal cannabis guidelines.
"This robust platform bridges the gap between clinical efficiency and patient convenience, providing holistic support for diagnosis, treatment, and follow-ups," the company said.
GPs and clinics will initially be able to access the platform through a free trial, after which OMG intends to introduce a monthly subscription model. Pricing has not been finalised but is expected to fall in the range of A$300–400 per month.
OMG founder and chair John Leith described Ask Sam as "a revolutionary step forward in healthcare".
He added: "By harnessing advanced AI, we're enabling practitioners to deliver exceptional care more efficiently while providing patients with immediate access to essential services.
"This launch underscores OMG's commitment to advancing accessible, high-quality healthcare for everyone."
Dr McDonald, a high-profile victim of the NSW Pharmaceutical Services Unit's recent crackdown on THC prescribing, said Ask Sam would help GPs work through the intricate regulatory requirements surrounding medicinal cannabis.
She said: "By supporting clinicians in real time and providing patients with immediate access to critical services, Ask Sam redefines what's possible in healthcare delivery. I'm excited to lead a platform that prioritises innovation, compliance, and quality care."
OMG CEO Rohit Bhuta said Dr McDonald's expertise and leadership will be "invaluable" to Ask Sam's mission.
He added: "Her insights into healthcare and compliance will be instrumental in realising the platform's potential as a trusted partner for clinicians and patients."
OMG said Ask Sam is expected to save healthcare practitioners up to two hours per day by reducing the administrative load, while patients stand to benefit from real-time consultations, instant prescription generation, and rapid dispensing.
"These features reduce wait times and create a seamless healthcare experience, empowering patients to take control of their health journey," the company added.
Though the platform's initial focus is medicinal cannabis, OMG said the underlying technology can be adapted for use across any healthcare speciality.
